Fund HoldingsDecheng Capital LLC

Total Portfolio Value
$743.41M
Total Bought
$11.63M
Total Sold
$63.73M
Net Transaction
-$52.10M
Filing Period:
Securities
SharesValue ($K)
Q3 2025
Q4 2025
Change
Q3 2025
Q4 2025
Weight (%)
Change
Nuvation Bio Inc.(NUVB)25,954,43925,954,439096,031232,55231.28%+136,520
Upstream Bio Inc.3,285,2933,143,078-142,21561,79685,33511.48%+23,538
Lyell Immunopharma, Inc.595,466692,050+96,5849,67021,3012.87%+11,631
CG ONCOLOGY INC(CGON)6,371,6696,371,6690256,651264,55235.59%+7,901
REVOLUTION MEDICINES INC(NSM)(RVMD)210,000200,000-10,0009,80715,9302.14%+6,123
Arcus Biosciences, Inc(RCUS)547,609541,559-6,0507,44712,9051.74%+5,458
Aclaris Therapeutics, Inc.4,041,7364,041,73607,67912,1661.64%+4,486
NEWAMSTERDAM PHARMA CO NV
ORDINARY SHARES
657,051592,057-64,99418,68720,7692.79%+2,083
Equillium Inc.4,447,3084,447,30806,3606,8930.93%+534
Nuvation Bio Inc.(NUVB)646,057646,05701152130.03%+98
Zentalis Pharmaceuticals Inc.1,323,3271,323,32701,9981,7860.24%-212
Pyxis Oncology, Inc (formerly Apexigen)326,810326,81007263760.05%-350
REZOLUTE INC59,90059,90005631410.02%-422
4D MOLECULAR THERAPEUTICS IN92,74844,311-48,4378063320.04%-474
GRAIL INC(GRAL)9,6840-9,6845730-573
AARDVARK THERAPEUTICS INC3,917,2993,917,299052,06151,4156.92%-646
Illumnia, Inc.(ILMN)7,9790-7,9797580-758
Aura Biosciences, Inc.515,555360,483-155,0723,1861,9650.26%-1,221
MOONLAKE IMMUNOTHERAPEUTICS181,6000-181,6001,3020-1,302
KRYSTAL BIOTECH INC(KRYS)32,30017,300-15,0005,7024,2650.57%-1,437
BeyondSpring Inc.4,286,1043,800,702-485,4027,7586,1950.83%-1,563
CRINETICS PHARMACEUTICALS IN(CRNX)143,00092,700-50,3005,9564,3150.58%-1,641
MERUS NV186,5460-186,54617,5630-17,563
Page 1 of 1